{"id":"NCT01721746","sponsor":"Bristol-Myers Squibb","briefTitle":"A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)","officialTitle":"A Randomized Open-Label Phase 3 Trial of BMS-936558 (Nivolumab) Versus Investigator's Choice in Advanced (Unresectable or Metastatic) Melanoma Patients Progressing Post Anti-CTLA-4 Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12-21","primaryCompletion":"2016-02-16","completion":"2020-12-29","firstPosted":"2012-11-06","resultsPosted":"2017-03-22","lastUpdate":"2022-04-19"},"enrollment":405,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Unresectable or Metastatic Melanoma"],"interventions":[{"type":"BIOLOGICAL","name":"BMS-936558","otherNames":[]},{"type":"DRUG","name":"Dacarbazine","otherNames":["DTIC-Dome","DTIC"]},{"type":"DRUG","name":"Carboplatin","otherNames":["Paraplatin","CBDCA"]},{"type":"DRUG","name":"Paclitaxel","otherNames":["Onxol"]}],"arms":[{"label":"BMS-936558 3 mg/kg (IV)","type":"EXPERIMENTAL"},{"label":"Investigator's Choice (Dacarbazine or Carboplatin+Paclitaxel)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to estimate the response rate and compare overall survival of patients taking BMS-936558 to those taking study physician's choice of either Dacarbazine or Carboplatin and Paclitaxel","primaryOutcome":{"measure":"Objective Response Rate (ORR)","timeFrame":"From date of randomization to the date of objectively documented progression, date of death, or the date of subsequent therapy (Up to approximately 38 months)","effectByArm":[{"arm":"Nivolumab","deltaMin":27.2,"sd":null},{"arm":"Investigator's Choice (Dacarbazine or Carboplatin+Paclitaxel)","deltaMin":9.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":7},"locations":{"siteCount":95,"countries":["United States","Austria","Belgium","Brazil","Canada","Denmark","France","Germany","Israel","Italy","Netherlands","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["28671856","25795410"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.bmsstudyconnect.com/s/US/English/USenHome","https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":191,"n":268},"commonTop":["Fatigue","Nausea","Diarrhoea","Arthralgia","Anaemia"]}}